🇺🇸 FDA
Patent

US 10722499

Anyhydrous compositions of mTOR inhibitors and methods of use

granted A61KA61K31/436A61K47/08

Quick answer

US patent 10722499 (Anyhydrous compositions of mTOR inhibitors and methods of use) held by PALVELLA THERAPEUTICS, INC. expires Mon Jul 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
PALVELLA THERAPEUTICS, INC.
Grant date
Tue Jul 28 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
29
CPC classes
A61K, A61K31/436, A61K47/08, A61K47/10, A61K47/12